The complaint centers on allegations that Microvast executives misled shareholders from April 1, 2025, through March 16, 2026. According to the court filing, the company failed to provide an accurate picture of its business health, specifically regarding inventory management and delays in customer vehicle rollouts. These issues reportedly undermined the firm’s ability to meet projected margin targets and stalled the critical Huzhou Phase 3.2 expansion, which had been slated for completion by the end of 2025.

Shareholders seeking to participate as lead plaintiffs must file a motion with the court no later than September 21, 2026. While the legal action remains in its preliminary stages and no class has been formally certified, the firm managing the case is soliciting inquiries from those who purchased securities during the specified class period. Investors retain the right to select their own counsel or opt to remain as absent class members without taking immediate action.